Jaguar Health, Inc.

JAGXCIK 0001585608 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K filed Apr 7, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:Material rewriteFull-doc fallback

Full filing:tone -0.0114Δ-0.011922% similar+2220/-557 ¶

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Jun 2, 20261.01 · Entry into a Material Definitive Agreeme3.02 · Unregistered Sales8.01 · Other Events9.01 · Financial Statements and Exhibits May 27, 20267.01 · Regulation FD Disclosure8.01 · Other Events9.01 · Financial Statements and Exhibits May 22, 20261.01 · Entry into a Material Definitive Agreeme8.01 · Other Events9.01 · Financial Statements and Exhibits May 20, 2026no items parsed May 19, 2026no items parsed

YoY shift: Bearish

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K. This filing is -1.19pp more bearish than last year's.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Jaguar Health, Inc.

Name	Roles	Filings
Chaturvedi Pravin R	Officer	13
Conte Lisa A	OfficerDirector	12
King Steven R.	Officer	12
Wolin Jonathan S.	Officer	12
Lizak Carol R.	Officer	10

Showing 1-5 of 10

Per pagePage 1 of 2Next

All filings

89 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Mar 12, 2026	Micek John Director	AGrant	7,377	$0.00	$0
Jan 21, 2026	Conte Lisa A See Remarks · Director	AGrant	28,592	$0.00	$0
Jan 21, 2026	Wolin Jonathan S. See Remarks	AGrant	11,740	$0.00	$0
Jan 21, 2026	King Steven R. See Remarks	AGrant	11,740	$0.00	$0
Dec 15, 2025	Lizak Carol R. Chief Financial Officer	AGrant	11,740	$0.00	$0

Showing 1-5 of 89

Per pagePage 1 of 18Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value